Article Details

Nipocalimab Gets Priority Review for Generalized Myasthenia Gravis - eMPR.com

Retrieved on: 2025-01-09 20:44:56

Tags for this article:

Click the tags to see associated articles and topics

Nipocalimab Gets Priority Review for Generalized Myasthenia Gravis - eMPR.com. View article details on hiswai:

Excerpt

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating immunoglobulin G antibodies. The Biologics ...

Article found on: www.empr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo